​​​​​​​Texas has had enough of the FDA’s indecision about a lethal injection drug it tried to import back in July 2015.

Amgen prevailed again in a PCSK9 patent case that could put Sanofi and Regeneron on the hook for double-digit royalties from their blockbuster hopeful Praluent.

Twenty states have unveiled a civil lawsuit accusing half a dozen drugmakers, including Mylan, Teva and Heritage, with generic drug price fixing just a day…

An ongoing patent infringement battle between Merck and Gilead over the latter’s hepatitis C blockbusters, Harvoni and Sovaldi, has swung back in Merck’s favor…

Should biosimilar makers have to give six months' notice to the original drugmaker after they receive FDA approval for their copycat version? The onus is…

After arresting a series of lower-level workers, the feds on Thursday hauled in former CEO Michael Babich and a group of other execs.

A former Bayer exec sued the company, claiming she was wrongfully terminated after she stood up for a pregnant colleague.

In 2013, it looked as if AstraZeneca and Ranbaxy could face billions in damages in a lawsuit alleging they struck an illegal deal to block a Nexium generic.…

Mylan flatly refused to testify at a committee hearing convened by Sen. Charles Grassley, who's questioning the EpiPen maker's ultraquick Medicaid-…

Legal